September 10, 2025

Wuling powder ameliorates diarrhea-predominant irritable bowel syndrome in mice by modulating gut mucosal microbiota and alleviating intestinal inflammation.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Experimental study shows Wuling powder reduces inflammation and regulates microbiota in IBS-D mice, suggesting its potential for therapy.

Wuling powder significantly reduces TNF-α and IL-6 levels in mice with irritable bowel syndrome.
Compared to the model control group, the treatment group exhibits increased MFGE8 and restored microbiota diversity.
16S rRNA high-throughput sequencing reveals a connection between microbiota changes and inflammation levels.
Findings support the potential of Wuling powder in clinical applications for managing irritable bowel syndrome.

Tian et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 10, 2025

View Full Paper

Ask AI

Bookmark

Authors

Experimental study shows Wuling powder reduces inflammation and regulates microbiota in IBS-D mice, suggesting its potential for therapy.

Wuling powder significantly reduces TNF-α and IL-6 levels in mice with irritable bowel syndrome.
Compared to the model control group, the treatment group exhibits increased MFGE8 and restored microbiota diversity.
16S rRNA high-throughput sequencing reveals a connection between microbiota changes and inflammation levels.
Findings support the potential of Wuling powder in clinical applications for managing irritable bowel syndrome.

Tian et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark